Understanding Your Fibroadenoma Diagnosis
At a Glance
A breast fibroadenoma is a common benign solid lump made of glandular and connective tissue. Doctors confirm it by matching the physical exam with imaging and, when needed, a biopsy; most simple fibroadenomas can be monitored rather than removed.
Discovering a lump in your breast often brings a wave of immediate anxiety. For many women, receiving a diagnosis of a fibroadenoma provides significant relief because it is a benign (non-cancerous) condition [1][2]. While any breast change requires a thorough evaluation, a fibroadenoma is not breast cancer, and having one does not mean you have cancer [2].
What is a Fibroadenoma?
A fibroadenoma is a common type of benign breast tumor known as a fibroepithelial neoplasm [2]. This term simply means the growth is a localized, harmless mass made up of two types of normal breast tissue that have grown more than usual:
- Glandular tissue: The parts of the breast that can produce milk [1].
- Stromal tissue: The connective “support” tissue that holds everything together [1].
Think of it as a localized “overgrowth” of the breast’s natural building blocks. Because it is a solid mass rather than a fluid-filled sac (which would be a cyst), it often feels like a firm, smooth, or rubbery marble that can be easily moved under the skin [2].
Who Gets Fibroadenomas?
If you have been diagnosed with a fibroadenoma, you are in very common company. They are the most frequent breast mass found in adolescents and young women [2][3]. While they can occur at any age, they are most common during the reproductive years.
In some specific screening studies of women between the ages of 18 and 40, ultrasound detected fibroadenomas in over a quarter of participants [4]. However, because they share physical traits with more serious conditions, self-diagnosis is never reliable; any new, persistent, or changing lump must be evaluated clinically by a healthcare professional.
Why Do They Develop?
Medical science does not yet have a single “reason” why fibroadenomas form, but several factors appear to play a role:
- Hormonal Sensitivity: Fibroadenomas are highly sensitive to hormones, particularly estrogen [5]. This is why they often appear during puberty or pregnancy and why they may shrink after menopause when hormone levels drop [6][1].
- Genetic Changes: Researchers have identified specific genetic markers (such as the MED12 gene mutation) in the stromal cells of many fibroadenomas [7]. These are “somatic” mutations, meaning they are limited to the lump itself and are not a genetic condition you pass on to children. While interesting to researchers, this does not currently affect your daily care.
- Reproductive Factors: Some evidence suggests that factors like age at first menstruation or having children may influence the likelihood of developing these growths, though the exact relationship is still being studied [8].
Understanding Your Diagnosis
Your care team likely used a combination of a physical exam, imaging (like an ultrasound or mammogram), and sometimes a biopsy (taking a small tissue sample) to confirm the diagnosis [9][10].
When these three pieces of information—the exam, the imaging, and the biopsy—all point to a fibroadenoma, doctors call this “concordance” [11]. A concordant diagnosis of a simple fibroadenoma is highly reliable.
Most fibroadenomas do not require surgery. Instead, they are often managed with observation, which involves periodic imaging to ensure the lump stays stable over time [12]. If a fibroadenoma is “simple” (meaning it has very specific, uniform features under a microscope), it generally does not increase your long-term risk of developing breast cancer beyond the risk shared by most women [13][14]. Details on how these are monitored or when they might be removed are covered in the treatment section of this guide.
Common questions in this guide
Is a fibroadenoma a type of breast cancer?
How do doctors confirm that a breast lump is a fibroadenoma?
What is the difference between a simple and complex fibroadenoma?
Do all fibroadenomas need to be removed?
Why do fibroadenomas develop or change in size?
Does having a simple fibroadenoma increase my risk of breast cancer?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What specific findings on my imaging or biopsy led to the diagnosis of a fibroadenoma rather than something else?
- 2.Is this a 'simple' or 'complex' fibroadenoma, and does that distinction change my follow-up plan?
- 3.Does my pathology report show any other findings, like 'proliferative changes' or 'atypia,' that I should know about?
- 4.Are my clinical exam, imaging results, and biopsy results all 'concordant' (in agreement)?
- 5.If we choose to monitor this with imaging, how often will I need scans and for how long?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (14)
- 1
Fibroepithelial tumours of the breast-a review.
Lerwill MF, Lee AHS, Tan PH
Virchows Archiv : an international journal of pathology 2022; (480(1)):45-63 doi:10.1007/s00428-021-03175-6.
PMID: 34505197 - 2
Genetics and genomics of breast fibroadenomas.
Loke BN, Md Nasir ND, Thike AA, et al.
Journal of clinical pathology 2018; (71(5)):381-387 doi:10.1136/jclinpath-2017-204838.
PMID: 29248888 - 3
Understanding Fibroadenoma of the Breast: A Comprehensive Review of Pre-operative and Post-operative Clinicopathological Correlations.
Pandit P, Murkey SP, Agarwal A, et al.
Cureus 2023; (15(12)):e51329 doi:10.7759/cureus.51329.
PMID: 38288219 - 4
Prevalence of breast fibroadenoma in healthy physical examination population in Guangdong province of China: a cross-sectional study.
Zhu L, Zeng X, Jiang S, et al.
BMJ open 2022; (12(6)):e057080 doi:10.1136/bmjopen-2021-057080.
PMID: 35760543 - 5
Fibroadenomas: a multidisciplinary review of the variants.
Basara Akin I, Balci P
Clinical imaging 2021; (71()):83-100 doi:10.1016/j.clinimag.2020.10.058.
PMID: 33186871 - 6
Giant breast fibroadenoma in pregnancy.
Krhovský Miroslav, Pilka Radovan, Fait Vuk, Eim Josef
Ceska gynekologie 2021; (86(2)):114-117 doi:10.48095/cccg2021114.
PMID: 34020558 - 7
Fibroepithelial lesions; The WHO spectrum.
Krings G, Bean GR, Chen YY
Seminars in diagnostic pathology 2017; (34(5)):438-452 doi:10.1053/j.semdp.2017.05.006.
PMID: 28688536 - 8
Family History, Reproductive, and Lifestyle Risk Factors for Fibroadenoma and Breast Cancer.
Li J, Humphreys K, Ho PJ, et al.
JNCI cancer spectrum 2018; (2(3)):pky051 doi:10.1093/jncics/pky051.
PMID: 31360866 - 9
Understanding BI-RADS Category 3.
Fazeli S, Stepenosky J, Guirguis MS, et al.
Radiographics : a review publication of the Radiological Society of North America, Inc 2025; (45(1)):e240169 doi:10.1148/rg.240169.
PMID: 39636752 - 10
The Positive Predictive Values of the Breast Imaging Reporting and Data System (BI-RADS) 4 Lesions and its Mammographic Morphological Features.
Mohapatra SK, Mishra A, Sahoo TK, et al.
Indian journal of surgical oncology 2021; (12(1)):182-189 doi:10.1007/s13193-020-01274-5.
PMID: 33814852 - 11
Correlation of Histopathology and Radiological Findings Among the Diverse Breast Lesions in a Tertiary Care Centre.
Mohan R, Selvakumar A S, S R, et al.
Cureus 2024; (16(1)):e52097 doi:10.7759/cureus.52097.
PMID: 38344545 - 12
Efficacy and Safety of Centchroman in the Treatment of Breast Fibroadenoma: A Systematic Review and Meta-Analysis.
Kumar K, Pallavi K, Martand K, et al.
Cureus 2025; (17(6)):e87046 doi:10.7759/cureus.87046.
PMID: 40741574 - 13
Breast fibroadenomas are not associated with increased breast cancer risk in an African American contemporary cohort of women with benign breast disease.
Shaik AN, Ruterbusch JJ, Abdulfatah E, et al.
Breast cancer research : BCR 2018; (20(1)):91 doi:10.1186/s13058-018-1027-6.
PMID: 30092846 - 14
Benign Breast Disease in Women.
Stachs A, Stubert J, Reimer T, Hartmann S
Deutsches Arzteblatt international 2019; (116(33-34)):565-574.
PMID: 31554551
This page explains breast fibroadenoma diagnoses for informational purposes only and does not constitute medical advice. Your clinician should interpret your imaging and pathology and recommend the right follow-up for you.
Get notified when new evidence is published on breast fibroadenoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.